Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Crestani (Paris, France), V. Cottin (Lyon , France), R. Thibault (Rennes, France), M. Lederlin (Rennes, France), L. Vernhet (Rennes, France), W. Stansen (Ingelheim am Rhein, Germany), M. Quaresma (Ingelheim am Rhein, Germany), S. Jouneau (Rennes, France). Association between weight loss and decline in FVC in patients with IPF. 1334

Member's Comments

No comment yet.

Related content which might interest you: FVC decline over 1 year predicts mortality but not subsequent FVC decline in patients with IPF Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Individual decline of FEV1 show diversity in COPD Source: Annual Congress 2012 - Environmental exposure and other risk factors for airway diseases Year: 2012 Association between third-space fluid and FEV1 in COPD patients Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 Relationship between body mass index (BMI) and decline in FVC in patients with IPF Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 Biomarkers to predict FEV1 decline in smokers and early-onset COPD. Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020 Distinguishing hyperinflation from combined restriction in patients with reduced FEV1/FVC and FVC on spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 202s Year: 2006 Monocyte count and decline in forced vital capacity (FVC) in patients with IPF Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020 The evaluation of different factors that cause FEV1 decline in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 135s Year: 2001 Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database Source: Annual Congress 2011 - Lung and airway function Year: 2011 Re-assessing the importance of FEV1 decline Source: Eur Respir Monogr 2015; 69: 134-142 Year: 2015 Changes in spirometry (FVC and FEV1) in a closed population of COPD patients using new standarized values for Mexican people Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003 Impact of the body mass index on the FEV1 value and its mean yearly decline in COPD patients Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 ADAM33 SNPs are associated with excess FEV1 decline in severe early onset COPD Source: Eur Respir J 2006; 28: Suppl. 50, 582s Year: 2006 Annual rate of FVC decline in patients with IPF treated with pirfenidone: Pooled analysis from 3 pivotal studies Source: International Congress 2016 – IPF treatment I Year: 2016 Association between lung function decline and occupational exposures in patients with COPD Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction Year: 2017 Short term Quantitative Lung Fibrosis (QLF) change predicts rapid rate of FVC decline in patients with IPF Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 LVRS does not accelerate rate of decline in FEV1 Source: Eur Respir J 2003; 22: Suppl. 45, 369s Year: 2003 Frequent exacerbations in COPD are associated with accelerated rate of FEV1 decline Source: Eur Respir J 2006; 28: Suppl. 50, 32s Year: 2006 Changes in FEV1 and SpO2 in patients with severe and very severe COPD Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021